Highlights of rising and falling U.S. stocks (Hepatitis C Treatment)

Highlights of rising and falling U.S. stocks
Investors Business Daily - Bally Total Fitness Holding ( BFT ) shares ended Tuesday's session with a 14.7% gain following a report that Virgin Group, run by billionaire Richard Branson, is mulling a takeover of the company. See full story. Shares of Corus Group Plc ( CGA

Antibodies Neutralizing Peginterferon Alfa during Retreatment of
New England Journal of Medicine - To the Editor: Peginterferons are widely used to treat chronic hepatitis C virus (HCV) infection, an important cause of liver cirrhosis and hepatocellular carcinoma. 1 , 2 , 3 , 4 We describe a patient who did not have a virologic response to

Britain: Breast cancer patient s legal challenge highlights rationing
World Socialist Web Site - Ann Marie Rogers, a 54-year-old breast cancer patient and mother of two, went to the Court of Appeal this week as part of her fight to receive the drug Herceptin free of charge under the National Health Service (NHS). Last month, Rogers lost her

16-Year follow-up study reinforces Betaseron long-term efficacy
EurekAlert - San Diego, CA Berlex announced today that Betaseron (interferon beta 1b) remained consistently safe, effective and well tolerated over the long term, according to results of the Betaseron 16-Year Long-Term Follow-up (16-Year LTF) Study

Protein lab test could spot MS early
LabTechnologist.com - 15/03/2006 - A new laboratory method, which looks for a spinal fluid protein, may identify people with the earliest stages of multiple sclerosis (MS), greatly increasing the effectiveness of drug therapies to treat the 10,000 Americans, who are

Novartis Seen 'Saving Face' With Idenix Hep C Deal
Forbes - Friedman, Billings, Ramsey reiterated an "outperform" rating on Idenix Pharmaceuticals after Swiss pharmaceutical titan Novartis exercised an option to co-develop the biotech firm's lead drug candidate. Novartis (nyse: NVS - news - people ) will pay

Advocacy Groups Charge Schering-Plough With Racial Discrimination For
Medical News Today - Two advocacy groups last week said Schering-Plough is discriminating against black people by excluding them from the Phase II clinical trial of its new hepatitis C therapy, the Newark Star-Ledger reports. The trial includes 300 patients around the